Immune DIREcted and Cancer-selective immunoTherapy
I-DireCT is a European Industrial Doctorate (EID) training network designed to provide training and carry out breakthrough research on the rapidly expanding and high impact field of cancer immunotherapy in a carefully integrated academic and inter-sectoral programme. Hereby, the consortium aims to develop next-generation immunotherapeutics and deliver a set of early stage researchers uniquely qualified for a career in academia and/or industry.
- Prof. Edwin BremerAcademisch Ziekenhuis GroningenEmail
- Horizon 2020 & sub-programmes
- 57 months (January 2019 - September 2023)
- Project funding
- € 2,533,358.34
- Project partners